Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.
BACKGROUND
Microtubule-associated protein tau (MAPT) has been associated with several neurodegenerative disorders including forms of parkinsonism and Parkinson disease (PD). We evaluated the association of the MAPT region with PD in a large cohort of familial PD cases recruited by the GenePD Study. In addition, postmortem brain samples from patients with PD and neurologically normal controls were used to evaluate whether the expression of the 3-repeat and 4-repeat isoforms of MAPT, and neighboring genes Saitohin (STH) and KIAA1267, are altered in PD cerebellum.


METHODS
Twenty-one single-nucleotide polymorphisms (SNPs) in the region of MAPT on chromosome 17q21 were genotyped in the GenePD Study. Single SNPs and haplotypes, including the H1 haplotype, were evaluated for association to PD. Relative quantification of gene expression was performed using real-time RT-PCR.


RESULTS
After adjusting for multiple comparisons, SNP rs1800547 was significantly associated with PD affection. While the H1 haplotype was associated with a significantly increased risk for PD, a novel H1 subhaplotype was identified that predicted a greater increased risk for PD. The expression of 4-repeat MAPT, STH, and KIAA1267 was significantly increased in PD brains relative to controls. No difference in expression was observed for 3-repeat MAPT.


CONCLUSIONS
This study supports a role for MAPT in the pathogenesis of familial and idiopathic Parkinson disease (PD). Interestingly, the results of the gene expression studies suggest that other genes in the vicinity of MAPT, specifically STH and KIAA1267, may also have a role in PD and suggest complex effects for the genes in this region on PD risk.
Tobin
J E
JE
Department of Anatomy, Physiology, and Genetics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA. jetobinphd@gmail.com
Latourelle
J C
JC
Lew
M F
MF
Klein
C
C
Suchowersky
O
O
Shill
H A
HA
Golbe
L I
LI
Mark
M H
MH
Growdon
J H
JH
Wooten
G F
GF
Racette
B A
BA
Perlmutter
J S
JS
Watts
R
R
Guttman
M
M
Baker
K B
KB
Goldwurm
S
S
Pezzoli
G
G
Singer
C
C
Saint-Hilaire
M H
MH
Hendricks
A E
AE
Williamson
S
S
Nagle
M W
MW
Wilk
J B
JB
Massood
T
T
Laramie
J M
JM
DeStefano
A L
AL
Litvan
I
I
Nicholson
G
G
Corbett
A
A
Isaacson
S
S
Burn
D J
DJ
Chinnery
P F
PF
Pramstaller
P P
PP
Sherman
S
S
Al-hinti
J
J
Drasby
E
E
Nance
M
M
Moller
A T
AT
Ostergaard
K
K
Roxburgh
R
R
Snow
B
B
Slevin
J T
JT
Cambi
F
F
Gusella
J F
JF
Myers
R H
RH
D000368:Aged; D001921:Brain / Q000378:metabolism / Q000473:pathology; D002886:Chromosomes, Human, Pair 17 / Q000235:genetics; D015331:Cohort Studies; D004252:DNA Mutational Analysis; D042622:DNA Repeat Expansion / Q000235:genetics; D005260:Female; D015870:Gene Expression / Q000235:genetics*; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005820:Genetic Testing; D014644:Genetic Variation / Q000235:genetics*; D005838:Genotype; D006239:Haplotypes / Q000235:genetics; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D016875:tau Proteins / Q000235:genetics*
C458340:STH protein, human; D016875:tau Proteins